Minerva Neurosciences, Inc.
NERV
$1.67
-$0.055-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 17.22% | 154.55% | 100.53% | 48.08% | 14.44% |
| Gross Profit | -17.22% | -154.55% | -100.53% | -48.08% | -14.44% |
| SG&A Expenses | -4.46% | 0.19% | -0.28% | -0.13% | -1.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.50% | 16.56% | 30.11% | 8.24% | -8.37% |
| Operating Income | 5.50% | -16.56% | -30.11% | -8.24% | 8.37% |
| Income Before Tax | 104.80% | 88.05% | -25.59% | -7.81% | 6.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 104.80% | 88.05% | -25.59% | -7.81% | 6.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 104.80% | 88.05% | -25.59% | -7.81% | 6.55% |
| EBIT | 5.50% | -16.56% | -30.11% | -8.24% | 8.37% |
| EBITDA | 5.50% | -53.62% | -165.62% | -357.20% | -- |
| EPS Basic | 104.08% | 90.73% | 10.75% | 18.38% | 22.60% |
| Normalized Basic EPS | 104.08% | 90.73% | 10.75% | 18.37% | 22.60% |
| EPS Diluted | 103.99% | 90.62% | 10.73% | 18.36% | 22.60% |
| Normalized Diluted EPS | 104.08% | 90.73% | 10.75% | 18.37% | 22.60% |
| Average Basic Shares Outstanding | 16.49% | 27.42% | 40.61% | 32.10% | 21.67% |
| Average Diluted Shares Outstanding | 16.49% | 27.42% | 40.61% | 32.10% | 21.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |